Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and (32)P-postlabelling

Lignende værker

• The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes
  af: Stiborová, Marie, et al.
  Udgivet: (2014)
• Cytochrome b(5) impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b(5)/P450 reductase null (HBRN) mice
  af: Reed, Lindsay, et al.
  Udgivet: (2018)
• The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers
  af: Šulc, Miroslav, et al.
  Udgivet: (2016)
• Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine
  af: Mrízová, Iveta, et al.
  Udgivet: (2016)
• Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[a]pyrene in prokaryotic and eukaryotic expression systems
  af: Stiborová, Marie, et al.
  Udgivet: (2017)